Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Drug Prices Enter Presidential Debate – Not That Anyone Noticed

Executive Summary

Second Presidential debate included the first direct discussion of health care issues by the candidates, and the first reference to prescription drug costs. The passing reference was, to put it mildly, overshadowed by other topics.


Related Content

Biopharma Goes 3 For 3 In Presidential Debates
Big Pharma’s Big Debate Win
Clinton Vs. Trump: Three Scenarios For Biopharma